Lash & Goldberg LLP resolved proceedings brought by the Securities & Exchange Commission against the Chief Executive Officer and Chief Financial Officer of a publicly traded consumer electronics retailer. The SEC charged the officers with violation of the securities laws in connection with certain alleged financial reporting and accounting improprieties. Following a lengthy investigation, the matter was resolved favorably for the Firm’s clients.
Lash & Goldberg LLP defended a shareholder derivative action on behalf of a director in a wireless cellular telephone company.
Lash & Goldberg LLP and its co-counsel obtained a dismissal in federal court, with prejudice, of an employee’s complaint to recover benefits under the Employee Retirement Income Security Act (ERISA) against a telecommunications company and its in-house counsel. The employee previously had asserted similar claims in a separate lawsuit and had released those claims as part of a negotiated settlement of that lawsuit.
Lash & Goldberg LLP defended a physician services company in arbitration before a retired state trial and appellate court judge against a physician’s $2 million breach of contract claim. The company had terminated the physician’s employment agreement on the grounds that he had breached his representations and warranties regarding the existence of a restrictive covenant with his former employer.
Lash & Goldberg LLP served as co-counsel for its named plaintiff client in this federal antitrust class action against Bristol-Myers alleging the unlawful monopolization of the national market for paclitaxel, a cancer drug sold under the brand name Taxol.